Pharmacokinetic Effect of AstraGin on Arginine Absorption and Nitric Oxide Production in Healthy Subjects
NCT05024123 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2021-08-27
Summary
AstraGin increases the absorption of amino acids and peptides in Caco-2 cells and in normal and TNBS-induced rats. Given the potential beneficial applications of AstraGin for health, the effects on L-arginine uptake and nitric oxide production are investigated. The study is the L-arginine pharmacokinetic study: A randomized, double-blind, crossover trial. This study performed in healthy human subjects. The knowledge gained from this study will provide valuable information for the development of novel and effective natural food supplements.
Conditions
- Absorption of Amino Acids and Peptides
Interventions
- DIETARY_SUPPLEMENT
-
Placebo
Before each study day, the participants were subjected to a reduced nitrate content diet (avoid foods such as dark chocolate, beets, garlic, nuts and seeds, bacon, ham, and hot dogs,, day-1) for 24h. All subjects took a 50 mg placebo (maltodextrin) capsule at 9 p.m. and began fasting for 12 hours, except for a small amount of water in the night before the experiment. On each study day, all subjects collected their first blood sample at 9 a.m. from the median cubital vein using the indwelling catheter method. After the first blood collection, all subjects took 50 mg placebo and 5 g of L-arginine with 250 mL water. Additional blood samples were collected at 0, 15, 30, 45, 60, 90, 120, 150, and 180 min for analysis of the plasma concentration of amino acids, total nitrite, nitrate, and asymmetric dimethylarginine (ADMA) content. All subjects collected their urine during 0 \~ 180 min to measure 1) nitrate and 2) cGMP content.
- DIETARY_SUPPLEMENT
-
AstraGin
Before each study day, the participants were subjected to a reduced nitrate content diet (avoid foods such as dark chocolate, beets, garlic, nuts and seeds, bacon, ham, and hot dogs,, day-1) for 24h. All subjects took a 50 mg placebo (maltodextrin) capsule at 9 p.m. and began fasting for 12 hours, except for a small amount of water in the night before the experiment. On each study day, all subjects collected their first blood sample at 9 a.m. from the median cubital vein using the indwelling catheter method. After the first blood collection, all subjects took 50 mg placebo and 5 g of L-arginine with 250 mL water. Additional blood samples were collected at 0, 15, 30, 45, 60, 90, 120, 150, and 180 min for analysis of the plasma concentration of amino acids, total nitrite, nitrate, and asymmetric dimethylarginine (ADMA) content. All subjects collected their urine during 0 \~ 180 min to measure 1) nitrate and 2) cGMP content.
Sponsors & Collaborators
-
Chung Shan Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-06
- Primary Completion
- 2021-10-31
- Completion
- 2022-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin
NCT02079506 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Safety and Pharmacokinetics of CKD-397
NCT02645890 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study of AG120 in Healthy Subjects
NCT02831972 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate
NCT02952040 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
NCT02233218 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers
NCT04237597 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study in Healthy Adult Volunteers
NCT02276001 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers
NCT02332044 ·Status: COMPLETED ·Phase: PHASE1
-
D5611C00003 - Food Interaction Study With AZD1722 Tablet in Healthy Subjects
NCT02226783 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Levocetirizine Oral Solution
NCT01622283 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects
NCT05106205 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects
NCT01088919 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects
NCT02397538 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants
NCT05965570 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers
NCT02089399 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of a Histamine H2 Receptor Antagonist (H2RA) on the Pharmacokinetics (PK) of Telaglenastat in Healthy Subjects
NCT04540965 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects
NCT02273505 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of CYP3A4 Inhibition on the Single Dose Pharmacokinetics of ASTX660 and the Effect of a Single Dose of ASTX660 on the Pharmacokinetics of the CYP3A4 Substrate Midazolam
NCT04411030 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Itraconazole on the Pharmacokinetics of Apatinib
NCT02836171 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects
NCT01104532 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study in Healthy Adult Volunteers
NCT02275988 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction (DDI) Study in Healthy Volunteers
NCT04814498 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State
NCT05108571 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine
NCT01363089 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
NCT02933658 ·Status: COMPLETED ·Phase: PHASE1